PTEN silencing lowers H3K27me3 and H3K27Ac enrichment in the Nkx3.1 promoter region and promotes alterations in DNA CpG methylation and transcriptome gene expression, associated with various inflammatory and immunological pathways in the development of prostate cancer (49). Here, PTEN is linked to prostate carcinoma.